Gritstone Bio Inc (NASDAQ: GRTS) is -90.16% lower on its value in year-to-date trading and has touched a low of $0.18 and a high of $3.33 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The GRTS stock was last observed hovering at around $0.19 in the last trading session, with the day’s gains setting it 0.01%.
Currently trading at $0.20, the stock is -56.40% and -58.74% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 6.77 million and changing 7.90% at the moment leaves the stock -84.01% off its SMA200. GRTS registered -92.96% loss for a year compared to 6-month loss of -79.49%. The firm has a 50-day simple moving average (SMA 50) of $0.4874 and a 200-day simple moving average (SMA200) of $1.2554.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -59.38% gain in the last 1 month and extending the period to 3 months gives it a -65.56%, and is -8.73% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 17.44% over the week and 16.67% over the month.
Gritstone Bio Inc (GRTS) has around 231 employees, a market worth around $23.70M and $0.50M in sales. Profit margin for the company is -26821.17%. Distance from 52-week low is 10.58% and -93.97% from its 52-week high. The company has generated returns on investments over the last 12 months (-113.20%).
with sales reaching $2.32M over the same period.The EPS is expected to grow by 29.72% this year, but quarterly earnings will post -65.70% year-over-year.
Gritstone Bio Inc (GRTS) Top Institutional Holders
98.0 institutions hold shares in Gritstone Bio Inc (GRTS), with institutional investors hold 34.01% of the company’s shares. The shares outstanding are 118.11M, and float is at 110.21M with Short Float at 6.02%. Institutions hold 33.36% of the Float.
The top institutional shareholder in the company is REDMILE GROUP, LLC with over 5.11 million shares valued at $3.16 million. The investor’s holdings represent 4.3143% of the GRTS Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 4.64 million shares valued at $2.87 million to account for 3.9225 of the shares outstanding. The other top investors are MORGAN STANLEY which holds 4.45 million shares representing 3.7621% and valued at over $2.75 million, while VERSANT VENTURE MANAGEMENT, LLC holds 3.008 of the shares totaling 3.56 million with a market value of $2.2 million.
Gritstone Bio Inc (GRTS) Insider Activity
The most recent transaction is an insider sale by Allen Andrew R, the company’s PRESIDENT AND CEO. SEC filings show that Allen Andrew R sold 24,263 shares of the company’s common stock on May 16 ’24 at a price of $0.75 per share for a total of $18156.0. Following the sale, the insider now owns 0.99 million shares.
Gritstone Bio Inc disclosed in a document filed with the SEC on May 16 ’24 that Jones Erin (EVP, CHIEF OPERATING OFFICER) sold a total of 13,749 shares of the company’s common stock. The trade occurred on May 16 ’24 and was made at $0.75 per share for $10288.0. Following the transaction, the insider now directly holds 0.36 million shares of the GRTS stock.
Still, SEC filings show that on May 16 ’24, Jooss Karin () disposed off 13,749 shares at an average price of $0.75 for $10288.0. The insider now directly holds 683,526 shares of Gritstone Bio Inc (GRTS).
